Home/Filings/4/0001209191-19-049377
4//SEC Filing

Levine Mitchell S 4

Accession 0001209191-19-049377

CIK 0001642380other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 6:33 PM ET

Size

4.9 KB

Accession

0001209191-19-049377

Insider Transaction Report

Form 4
Period: 2019-09-12
Levine Mitchell S
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, no par value

    2019-09-12$2.01/sh+10,000$20,06010,000 total
Footnotes (1)
  • [F1]The price of $2.006 per share represents a weighted average of prices ranging from $2.003 to $2.006 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Issuer

OncoCyte Corp

CIK 0001642380

Entity typeother

Related Parties

1
  • filerCIK 0001383492

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 6:33 PM ET
Size
4.9 KB